Use of scalp cooling therapy in patients with breast or gynecological cancers undergoing chemotherapy may be associated with a higher risk of systemic recurrence

Affiliations

Comment

Kadri Altundag. Support Care Cancer. 2025.

. 2025 Jan 5;33(1):70.

doi: 10.1007/s00520-025-09151-z.

¹ MKA Breast Cancer Clinic, Tepe Prime, Cankaya, 06800, Ankara, Turkey. altundag66@yahoo.com.

No abstract available

Conflict of interest statement

Declarations. Competing interest: The authors declare no competing interests.

Scalp cooling therapy for chemotherapy-induced hair loss in patients with breast or gynecological cancers-an Asian tertiary institution experience.
Lee VGH, Loh J, Hui F, Sundar R, Tan B, Lee MC, Lin HY, Ong LC, Visvanadan N, Ow SGW, Wong ALA, Chan GHJ, Lim SE, Lim YW, Tan DSP, Ang Y, Choo J, Lee MXW, Ngoi NYL, Lee SC, Paxman R, Parker A, Lee YM, Lim JSJ. Lee VGH, et al. Support Care Cancer. 2024 Nov 1;32(11):762. doi: 10.1007/s00520-024-08940-2. Support Care Cancer. 2024. PMID: 39482416

1. Lee VGH, Loh J, Hui F et al (2024) Scalp cooling therapy for chemotherapy-induced hair loss in patients with breast or gynecological cancers-an Asian tertiary institution experience. Support Care Cancer 32:762. https://doi.org/10.1007/s00520-024-08940-2 - DOI - PubMed
1. Rugo HS, Melin SA, Voigt J (2017) Scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis. Breast Cancer Res Treat 163:199–205 - DOI - PubMed - PMC
1. Lee JS, Magbanua MJ, Park JW (2016) Circulating tumor cells in breast cancer: applications in personalized medicine. Breast Cancer Res Treat 160:411–424 - DOI - PubMed
1. Altundag K (2021) Probable association between increased systemic recurrence and the use of scalp cooling in breast cancer patients receiving (neo)adjuvant chemotherapy. Support Care Cancer 29:1151 - DOI - PubMed